Skip to main content
EMV CAPITAL PLC logo

EMV CAPITAL PLC — Investor Relations & Filings

Ticker · EMVC ISIN · GB00BN4R5Q82 LEI · 213800N5WD46G1Y7I458 IL Financial and insurance activities
Open in API
Filings indexed 547 across all filing types
Latest filing 2022-06-21 Capital/Financing Update
Country GB United Kingdom
Listing IL EMVC

About EMV CAPITAL PLC

https://www.emvcapital.com/

EMV Capital PLC is a venture capital investment group specializing in deep tech and life sciences. The firm identifies, invests in, and builds high-growth, IP-rich companies with an international portfolio, focusing on sectors including industrial technology, healthcare, and sustainability. It employs a capital-efficient investment strategy that combines syndicated investments, direct balance sheet funding, and managed funds to support companies from their early stages through to successful exit. EMV Capital engages in proactive portfolio management, often taking board positions and working closely with company leadership. It provides extensive value creation services, including support for fundraising, exit readiness, IP strategy, and corporate collaborations, to drive growth and maximize returns for investors through strategic exits.

Recent filings

Filing Released Lang Actions
Proposed Placing to raise at least £1.5 million
Capital/Financing Update Classification · 100% confidence The document is an announcement by NetScientific PLC regarding a proposed equity fundraising (placing of new ordinary shares). It details the purpose of the raise, the number of shares, the price, and the involvement of a broker (WH Ireland). This fits the definition of a 'Capital/Financing Update' (CAP) as it describes a specific fundraising activity and capital structure change. It is not a report itself, but an announcement of a transaction.
2022-06-21 English
NetScientific to increase Q-Bot stake to 23.7%
Regulatory Filings Classification · 98% confidence The document is a press release distributed via the RNS Reach service, which is a non-regulatory news distribution platform. The content details a specific corporate action: NetScientific PLC increasing its equity stake in a portfolio company, Q-Bot. This type of announcement regarding investment activity and capital allocation does not fit into the specific categories for financial reports, proxy statements, or governance filings. As it is a general corporate announcement regarding business operations and investment, it falls under the 'Regulatory Filings' (RNS) category as the fallback for miscellaneous corporate news.
2022-06-17 English
Q-Bot secures £1.6m of investment to fund growth
Regulatory Filings Classification · 98% confidence The document is a press release issued via the RNS Reach service, announcing that a portfolio company (Q-Bot) has secured £1.6m in investment. The text details the funding round, the impact on NetScientific's equity stake, and the growth strategy of the portfolio company. Since this is an announcement regarding financing and capital structure changes for a company within the group, it falls under the Capital/Financing Update category.
2022-06-15 English
Notice of AGM and Annual Report & Accounts
Report Publication Announcement Classification · 100% confidence The document is a short announcement (under 5,000 characters) from NetScientific PLC stating that the Annual Report and Accounts and the Notice of Annual General Meeting have been sent to shareholders and are available on the company's website. Per the 'Menu vs Meal' rule, this is an announcement of the publication of reports rather than the reports themselves, making it a Report Publication Announcement (RPA).
2022-06-07 English
PDS Granted FDA Fast Track Designation for PDS0101
Regulatory Filings Classification · 95% confidence The document is a press release issued via the Regulatory News Service (RNS) regarding a portfolio company of NetScientific PLC receiving FDA Fast Track designation. It does not fit into specific categories like financial reports, dividend notices, or director dealings. As it is a general corporate announcement regarding business operations and regulatory milestones, it falls under the 'Regulatory Filings' (RNS) category.
2022-06-06 English
PDS Biotech - new data for ongoing clinical trials
Regulatory Filings Classification · 98% confidence The document is a press release distributed via the London Stock Exchange's 'Reach' service. It provides an update on clinical trial results for a portfolio company (PDS Biotechnology) of NetScientific PLC. It does not constitute a formal financial report, regulatory filing, or earnings release, but rather a corporate news announcement regarding operational/clinical progress. As it is a general corporate announcement that does not fit into specific categories like M&A or Board changes, it falls under the 'Regulatory Filings' (RNS) category as the designated fallback for miscellaneous announcements.
2022-05-27 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.